0001104659-20-019980.txt : 20200213 0001104659-20-019980.hdr.sgml : 20200213 20200213131555 ACCESSION NUMBER: 0001104659-20-019980 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200213 DATE AS OF CHANGE: 20200213 EFFECTIVENESS DATE: 20200213 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ENB Therapeutics, Inc. CENTRAL INDEX KEY: 0001753420 IRS NUMBER: 473954174 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-321893 FILM NUMBER: 20608696 BUSINESS ADDRESS: STREET 1: C/O ALEXANDRIA CENTER FOR LIFE SCIENCES STREET 2: LAUNCHLABS 430 E 29TH ST. 14TH FLOOR CITY: NEW YORK STATE: NY ZIP: 100116 BUSINESS PHONE: 212 792-2317 MAIL ADDRESS: STREET 1: C/O ALEXANDRIA CENTER FOR LIFE SCIENCES STREET 2: LAUNCHLABS 430 E 29TH ST. 14TH FLOOR CITY: NEW YORK STATE: NY ZIP: 100116 D/A 1 primary_doc.xml X0708 D/A LIVE 0001753420 ENB Therapeutics, Inc. C/O LAUNCHLABS 430 E. 29TH ST., 14TH FLOOR NEW YORK NY NEW YORK 10016 (212) 792-2317 DELAWARE None None Corporation true 2018 Sumayah Jamal c/o LaunchLabs 430 E. 29th St., 14th Floor NEW YORK NY NEW YORK 10016 Executive Officer Director Fumitaka Mori c/o LaunchLabs 430 E. 29th St., 14th Floor NEW YORK NY NEW YORK 10016 Director Barbara Schilberg c/o LaunchLabs 430 E. 29th St., 14th Floor NEW YORK NY NEW YORK 10016 Director Albert Sokol c/o LaunchLabs 430 E. 29th St., 14th Floor NEW YORK NY NEW YORK 10016 Executive Officer Biotechnology Decline to Disclose 06b true 0001144204-18-050283 2018-09-07 true true false 0 9094584 8094584 1000000 false 17 0 0 0 None except for normal operational expenses. false ENB Therapeutics, Inc. /s/Albert Sokol Albert Sokol Secretary 2020-02-13